Dr. Myron Cohen, an HPTN principal investigator, is director of the Institute for Global Health and Infectious Diseases at the University of North Carolina (UNC) at Chapel Hill. He is also the Yeargan-Bate Distinguished Professor of Medicine, Microbiology, and Immunology and Epidemiology at UNC. Dr. Cohen was the architect and leader of HPTN 052, the study that demonstrated successful suppression of HIV replication with antiretroviral agents prevents transmission. Subsequently, the earliest possible treatment of HIV for individual and community benefit became a global standard of care. In 2011, Dr. Cohen received the North Carolina Science Award, the state’s highest civilian honor. He is a member of the National Academy of Medicine and has been part of the HPTN since its inception.
